series-a
Stage
1
Investors
About
Eilean Therapeutics develops small molecule oncology therapies targeting major drivers of cancer resistance in hematologic malignancies, including pan-variant and mutation-specific inhibitors advancing towards clinical development.
Explore Eilean Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.